首页>美国卫生研究院文献>ESMO Open

ESMO Open

【机译】：EsmO开放

ISSN：-
出版周期：
语言：English

起始发布年份：2016
出版者：London : BMJ, [2016]-
出版地：England

NLM刊名缩写：ESMO Open

数据库引入：PubMed: v1n1, 2016-, PMC

MeSH词表主题词：Neoplasms*

备注：Numbering from table of contents page. Description based on: Volume 1, issue 1展开▼

期刊论文

热门论文

年度选择

2021
- Volume 6(1) 2021 Feb
- Volume 6(2) 2021 Apr
2020
2019
2018
2017
2016

更多>>

全选（0）

1.Clinical outcomes of patients with breast cancer relapsing after (neo)adjuvant trastuzumab and receiving trastuzumab rechallenge or lapatinib-based therapy: a multicentre retrospective cohort study

机译：乳腺癌患者的临床结果复发（Neo）佐剂曲妥珠单抗和接受曲妥珠单抗的重新检查或基于Lapatinib的疗法：多期回顾性队列研究
- 作者：Eva Blondeaux;Arlindo R Ferreira;Francesca Poggio;Fabio Puglisi;Claudia Bighin;Federico Sottotetti;Filippo Montemurro;Elena Poletto;Antonella Lai;Valentina Sini;Gabriele Minuti;Silvia Mura;Andrea Fontana;Piero Fregatti;Barbara Cardinali;Matteo Lambertini;Lucia Del Mastro
- 期刊名称：《ESMO Open》 | 2020年第4期
2.Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan

机译：临床常规癌症治疗中高通量测序的可行性：法国基因组医学癌症试点项目的课程2025计划
- 作者：Céline Auzanneau;Delphine Bacq;Carine Bellera;Hélène Blons;Anne Boland;Marlène Boucheix;Aurélien Bourdon;Emmanuelle Chollet;Christine Chomienne;Jean-François Deleuze;Christelle Delmas;Derek Dinart;Hélène Espérou;Flore Geillon;Damien Geneste;Antoine Italiano;Delphine Jean;Emmanuel Khalifa;Yechan Laizet;Pierre Laurent-Puig;Franck Lethimonnier;Claire Lévy-Marchal;Carlo Lucchesi;Carine Malle;Pierre Mancini;Simone Mathoulin-Pélissier;Vincent Meyer;Palomares Marie-Ange;Géraldine Perkins;Sabrina Sellan-Albert;Isabelle Soubeyran;Cédric Wallet
- 期刊名称：《ESMO Open》 | 2020年第4期
3.Effect of trifluridine/tipiracil in patients treated in RECOURSE by prognostic factors at baseline: an exploratory analysis

机译：基线预后因子伴随患者Trifluridine / Tipiracil的影响：探索性分析
- 作者：Josep Tabernero;Guillem Argiles;Alberto F Sobrero;Christophe Borg;Atsushi Ohtsu;Robert J Mayer;Loick Vidot;Shanti R Moreno Vera;Eric Van Cutsem
- 期刊名称：《ESMO Open》 | 2020年第4期
4.Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanoma

机译：单疗法与脑转移的响应评估与结合恶性黑素瘤脑转移的结果
- 作者：Emilie Le Rhun;Fabian Wolpert;Maud Fialek;Patrick Devos;Nicolaus Andratschke;Nicolas Reyns;Luca Regli;Reinhard Dummer;Laurent Mortier;Michael Weller
- 期刊名称：《ESMO Open》 | 2020年第4期
5.Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group

机译：用细胞周期蛋白依赖性激酶4/6（CDK4 / 6）抑制剂与内分泌治疗相关的高乳腺癌患者的现实临床结果和经济方面：Hellenic合作肿瘤学团体的经验
- 作者：Elena Fountzilas;Georgia-Angeliki Koliou;Athanassios Vozikis;Vassiliki Rapti;Achilleas Nikolakopoulos;Anastasios Boutis;Athina Christopoulou;Ioannis Kontogiorgos;Sofia Karageorgopoulou;Efthalia Lalla;Dimitrios Tryfonopoulos;Ioannis Boukovinas;Cleopatra Rapti;Adamantia Nikolaidi;Sofia Karteri;Evangelia Moirogiorgou;Ioannis Binas;Davide Mauri;Gerasimos Aravantinos;Flora Zagouri;Zacharenia Saridaki;Amanda Psyrri;Dimitrios Bafaloukos;Anna Koumarianou;Eleni Res;Helena Linardou;Giannis Mountzios;Evangelia Razis;George Fountzilas;Georgios Koumakis
- 期刊名称：《ESMO Open》 | 2020年第4期
6.Improved efficacy of taxanes and ramucirumab combination chemotherapy after exposure to anti-PD-1 therapy in advanced gastric cancer

机译：在晚期胃癌中暴露于抗PD-1治疗后提高了紫杉烷和Ramucirumab组合化疗的疗效
- 作者：Akinori Sasaki;Akihito Kawazoe;Testuya Eto;Mashiro Okunaka;Saori Mishima;Kentaro Sawada;Yoshiaki Nakamura;Daisuke Kotani;Yasutoshi Kuboki;Hiroya Taniguchi;Takashi Kojima;Toshihiko Doi;Takayuki Yoshino;Tetsuo Akimoto;Kohei Shitara
- 期刊名称：《ESMO Open》 | 2020年第4期
7.Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503)

机译：Lenvatinib对转移结直肠癌难以解决标准化疗的II期研究：柠檬研究（NCCH1503）
- 作者：Satoru Iwasa;Natsuko Okita;Aya Kuchiba;Gakuto Ogawa;Mamiko Kawasaki;Kenichi Nakamura;Hirokazu Shoji;Yoshitaka Honma;Atsuo Takashima;Ken Kato;Tetsuya Hamaguchi;Narikazu Boku;Yasuhide Yamada
- 期刊名称：《ESMO Open》 | 2020年第4期
8.Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study

机译：（Neo）佐剂化疗在昂贵arcoma中的使用和疗效评估：多期面研究
- 作者：Anastasia Constantinidou;Nicolas Sauve;Silvia Stacchiotti;Jean-Yves Blay;Bruno Vincenzi;Giovanni Grignani;Piotr Rutkowski;Michele Guida;Nadia Hindi;Alexander Klein;Valentin Thibaud;Jozef Sufliarsky;Ingrid Desar;Neeltje Steeghs;Saskia Litiere;Hans Gelderblom;Robin L Jones
- 期刊名称：《ESMO Open》 | 2020年第4期
9.Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials

机译：用于肝细胞癌患者和α-胎蛋白患者的二线中的RAMUCILUMAB：患者报告的两种随机临床试验
- 作者：Andrew X Zhu;Ryan D Nipp;Richard S Finn;Peter R Galle;Josep M Llovet;Jean-Frederic Blanc;Takuji Okusaka;Ian Chau;David Cella;Allicia Girvan;Jonathon Gable;Lee Bowman;Chunxiao Wang;Yanzhi Hsu;Paolo B Abada;Masatoshi Kudo
- 期刊名称：《ESMO Open》 | 2020年第4期
10.Positive tumour CD47 expression is an independent prognostic factor for recurrence in resected non-small cell lung cancer

机译：阳性肿瘤CD47表达是切除的非小细胞肺癌复发的独立预后因素
- 作者：Yan Xu;Ji Li;Bing Tong;Minjiang Chen;Xiaoyan Liu;Wei Zhong;Jing Zhao;Mengzhao Wang
- 期刊名称：《ESMO Open》 | 2020年第4期
11.Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis

机译：基于内分泌治疗的激素受体阳性/ HER2阴性晚期乳腺癌治疗方法：系统审查和网络META分析
- 作者：Mariana Brandão;Christian Maurer;Patricia Klarmann Ziegelmann;Noam F Pondé;Arlindo Ferreira;Samuel Martel;Martine Piccart;Evandro de Azambuja;Márcio Debiasi;Matteo Lambertini
- 期刊名称：《ESMO Open》 | 2020年第4期
12.Oncological care organisation during COVID-19 outbreak

机译：Covid-19爆发期间的肿瘤治疗组织
- 作者：Concetta Elisa Onesti;Hope S Rugo;Daniele Generali;Marc Peeters;Khalil Zaman;Hans Wildiers;Nadia Harbeck;Miguel Martin;Massimo Cristofanilli;Javier Cortes;Vivianne Tjan-Heijnen;Sara A Hurvitz;Guy Berchem;Marco Tagliamento;Mario Campone;Rupert Bartsch;Sabino De Placido;Fabio Puglisi;Sylvie Rottey;Volkmar Müller;Thomas Ruhstaller;Jean-Pascal Machiels;PierFranco Conte;Ahmad Awada;Guy Jerusalem
- 期刊名称：《ESMO Open》 | 2020年第4期
13.Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors

机译：由于PD-1和PD-L1检查点抑制剂引起的分枝杆菌感染
- 作者：Kartik Anand;Geetanjali Sahu;Ethan Burns;Allyne Ensor;Joe Ensor;Sai Ravi Pingali;Vivek Subbiah;Swaminathan P Iyer
- 期刊名称：《ESMO Open》 | 2020年第4期
14.Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer

机译：预测生物标志物的当前状态和未来潜力免疫检查点抑制剂在胃癌中的抑制剂
- 作者：Byung Woog Kang;Ian Chau
- 期刊名称：《ESMO Open》 | 2020年第4期
15.How I treat neuroendocrine tumours

机译：我如何治疗神经内分泌肿瘤
- 作者：Barbara Kiesewetter;Markus Raderer
- 期刊名称：《ESMO Open》 | 2020年第4期
16.How I treat MALT lymphoma: ‘a subjective interpretation of the gospel according to Isaacson….’

机译：如何治疗麦芽淋巴瘤：根据伊萨克森的主观解释福音......
- 作者：Markus Raderer;Barbara Kiesewetter
- 期刊名称：《ESMO Open》 | 2020年第4期
17.Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspects

机译：先进/转移性肾细胞癌患者的一线治疗中的组合：监管方面
- 作者：Luca Moscetti;Paula Hennik;Bjorg Bolstad;Jorge Camarero;Filip Josephson;Daniela Melchiorri;Maja Sommerfelt Grønvold;Jan Sjoberg;Mihaela Botezatu;Jorn Mulder;Didier Meulendijks;Ana Trullas Jimeno;Nikolaos Zafiropoulos;Jonas Bergh;Harald Enzmann;Francesco Pignatti
- 期刊名称：《ESMO Open》 | 2020年第4期
18.Calling for advocacy education and public policy actions on pain control for patients with cancer in Africa

机译：在非洲癌症患者的疼痛控制中呼吁宣传教育和公共政策作用
- 作者：Rene Krause;Anna Nyakabau;Liz Gwyther Gwyther;Emmanuel Luyirika;Stein Kaasa
- 期刊名称：《ESMO Open》 | 2020年第4期
19.Systemic chemotherapy for gastro-oesophagogastric junction adenocarcinoma and stomach adenocarcinoma in a metastatic setting

机译：胃卵囊胃癌结腺癌和胃腺癌在转移环境中的全身化疗
- 作者：Aravind Sanjeevaiah;Elizabeth McGehee
- 期刊名称：《ESMO Open》 | 2020年第4期
20.Pain workshop ESMO: Africa (response)

机译：痛苦研讨会Esmo：非洲（回应）
- 作者：Liz Grant;Mhoira Leng;Marie Fallon
- 期刊名称：《ESMO Open》 | 2020年第4期
21.Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?

机译：在目前的Covid-19在意大利的爆发期间多尾测定可以扩大他们在早期乳腺癌治疗选择中的临床有用性吗？
- 作者：Alberto Zambelli;Carlo Alberto Tondini
- 期刊名称：《ESMO Open》 | 2020年第4期
22.Hormonal control of cancer: an outdated topic?

机译：癌症的激素控制：过时的话题？
- 作者：Maximilian Marhold
- 期刊名称：《ESMO Open》 | 2020年第4期
23.Supplemental parenteral nutrition: decisions based on weak evidence

机译：补充肠外营养：基于弱证据的决策
- 作者：Jann Arends;Karin Jordan
- 期刊名称：《ESMO Open》 | 2020年第4期
24.PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come

机译：pik3ca激素受体阳性乳腺癌中的突变抑制：时间已经到来
- 作者：Leticia De Mattos-Arruda
- 期刊名称：《ESMO Open》 | 2020年第4期
25.In the literature: August 2020

机译：在文献中：2020年8月
- 作者：Valentina Gambardella;Juan-Miguel Cejalvo;Noelia Tarazona;Andrés Cervantes
- 期刊名称：《ESMO Open》 | 2020年第4期
26.Correction: Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinion

机译：矫正：前列腺癌疾病连续内的骨骼健康管理：对专家小组意见的证据审查
- 期刊名称：《ESMO Open》 | 2020年第4期
27.Gender-specific aspects related to type of fertility preservation strategies and access to fertility care

机译：与生育保存策略类型的性别特定的方面以及获得生育护理
- 作者：Marta Perachino;Claudia Massarotti;Maria Grazia Razeti;Francesca Parisi;Luca Arecco;Alessandra Damassi;Piero Fregatti;Cinzia Solinas;Matteo Lambertini
- 期刊名称：《ESMO Open》 | 2020年第Suppl 4期
28.Gender-specific aspects of epidemiology molecular genetics and outcome: lung cancer

机译：流行病学的性别特异性方面分子遗传学和结果：肺癌
- 作者：Nuria Mederos;Alex Friedlaender;Solange Peters;Alfredo Addeo
- 期刊名称：《ESMO Open》 | 2020年第Suppl 4期
29.Sex-specific and gender-specific aspects in patient-reported outcomes

机译：患者报告的结果中的性别特异性和性别特异性方面
- 作者：Caroline Hertler;Annina Seiler;Dorothee Gramatzki;Markus Schettle;David Blum
- 期刊名称：《ESMO Open》 | 2020年第Suppl 4期
30.Sex-specific aspects of epidemiology molecular genetics and outcome: primary brain tumours

机译：流行病学的性别特异性方面分子遗传学和结果：原发性脑肿瘤
- 作者：Emilie Le Rhun;Michael Weller
- 期刊名称：《ESMO Open》 | 2020年第Suppl 4期
31.Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines

机译：不同治疗系中转移肾细胞癌中免疫检查点抑制剂的结果
- 作者：I. Resch;A. Bruchbacher;J. Franke;H. Fajkovic;M. Remzi;S.F. Shariat;M. Schmidinger
- 期刊名称：《ESMO Open》 | 2021年第4期
32.Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity efficacy and prognostic biomarker data of phase II clinical trials

机译：肽受体放射性核素治疗患者转移性培育性嗜铬细胞瘤和伞形脑瘤：长期毒性疗效和预后生物标志物数据的II期临床试验
- 作者：S. Severi;A. Bongiovanni;M. Ferrara;S. Nicolini;F. Di Mauro;M. Sansovini;I. Lolli;E. Tardelli;C. Cittanti;V. Di Iorio;E. Mezzenga;E. Scarpi;T. Ibrahim;G. Paganelli;S. Zovato
- 期刊名称：《ESMO Open》 | 2021年第4期
33.Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma

机译：具有促进性淋巴瘤激酶抑制剂Ceritinib的精确治疗ALK-REATRANGED anaplastic大细胞淋巴瘤
- 作者：V. Subbiah;S. Kuravi;S. Ganguly;D.R. Welch;C.J. Vivian;M.U. Mushtaq;A. Hegde;S. Iyer;A. Behrang;S.M. Ali;R.W. Madison;J.M. Venstrom;R.A. Jensen;J.P. McGuirk;H.M. Amin;R. Balusu
- 期刊名称：《ESMO Open》 | 2021年第4期
34.Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery

机译：用前期手术治疗口腔鳞状细胞癌患者肿瘤突变负担的预后价值
- 作者：A. Moreira;A. Poulet;J. Masliah-Planchon;C. Lecerf;S. Vacher;L. Larbi Chérif;C. Dupain;G. Marret;E. Girard;L. Syx;C. Hoffmann;E. Jeannot;J. Klijanienko;I. Guillou;O. Mariani;A. Dubray-Vautrin;N. Badois;M. Lesnik;O. Choussy;V. Calugaru;E. Borcoman;S. Baulande;P. Legoix;B. Albaud;N. Servant;I. Bieche;C. Le Tourneau;M. Kamal
- 期刊名称：《ESMO Open》 | 2021年第4期
35.Impact of tumor growth rate during preceding treatment on tumor response to nivolumab or irinotecan in advanced gastric cancer

机译：在晚期胃癌中肿瘤反应前治疗肿瘤生长速率的影响治疗晚期胃癌中的Nivolumab或Irinotecan
- 作者：K. Kato;T. Masuishi;K. Fushiki;S. Nakano;Y. Kawamoto;Y. Narita;T. Tsushima;K. Harada;S. Kadowaki;A. Todaka;S. Yuki;M. Tajika;N. Machida;Y. Komatsu;H. Yasui;K. Muro;T. Kawakami
- 期刊名称：《ESMO Open》 | 2021年第4期
36.Clinical benefits of precision medicine in treating solid cancers: European Society of Medical Oncology-Magnitude of Clinical Benefit Scale score-based analysis

机译：精密医学治疗固体癌症的临床益处：欧洲医学肿瘤学会 - 基于临床效益规模评分分析分析
- 作者：Y. Hibino;M. Ito;T. Satake;S. Kondo
- 期刊名称：《ESMO Open》 | 2021年第4期
37.Quality of life with first-line pembrolizumab for PD-L1–positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study

机译：用第一线Pembrolizumab为PD-L1阳性晚期胃/胃食管管接线腺癌的生活质量：随机阶段III keynote-062研究结果
- 作者：E. Van Cutsem;A. Valderrama;Y.-J. Bang;C.S. Fuchs;K. Shitara;Y.Y. Janjigian;S. Qin;T.G. Larson;V. Shankaran;S. Stein;J.M. Norquist;U. Kher;S. Shah;M. Alsina
- 期刊名称：《ESMO Open》 | 2021年第4期
38.Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma

机译：先进肝细胞癌递归分配分析的鉴定Lenvatinib预后指数
- 作者：I.G. Rapposelli;S. Shimose;T. Kumada;S. Okamura;A. Hiraoka;G.G. Di Costanzo;F. Marra;E. Tamburini;A. Forgione;F.G. Foschi;M. Silletta;S. Lonardi;G. Masi;M. Scartozzi;M. Nakano;H. Shibata;K. Kawata;A. Pellino;C. Vivaldi;E. Lai;A. Takata;K. Tajiri;H. Toyoda;R. Tortora;C. Campani;M.G. Viola;F. Piscaglia;F. Conti;C.A.M. Fulgenzi;G.L. Frassineti;M.D. Rizzato;F. Salani;G. Astara;T. Torimura;M. Atsukawa;T. Tada;V. Burgio;M. Rimini;S. Cascinu;A. Casadei-Gardini
- 期刊名称：《ESMO Open》 | 2021年第4期
39.Gefitinib induction followed by chemoradiotherapy in EGFR-mutant locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study

机译：Gefitinib诱导随后在EGFR-突变体局部晚期非小细胞肺癌中的化学疗法：Logik0902 / OLCSG0905期II研究
- 作者：K. Hotta;S. Saeki;M. Yamaguchi;D. Harada;A. Bessho;K. Tanaka;K. Inoue;K. Gemba;M. Shiojiri;Y. Kato;T. Ninomiya;T. Kubo;J. Kishimoto;Y. Shioyama;K. Katsui;J. Sasaki;K. Kiura;K. Sugio
- 期刊名称：《ESMO Open》 | 2021年第4期
40.Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.1

机译：通过应用临床福利规模的ESMO-级（ESMO-MCBS）版本1.1奥地利奥地利转移性实体肿瘤使用的成本效益分析
- 作者：M. Pichler;J. Steyrer
- 期刊名称：《ESMO Open》 | 2021年第4期
41.Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3

机译：通过测量血浆CA 15.3测量检测二次转移性乳腺癌
- 作者：L. De Cock;J. Heylen;A. Wildiers;K. Punie;A. Smeets;C. Weltens;P. Neven;J. Billen;A. Laenen;H. Wildiers
- 期刊名称：《ESMO Open》 | 2021年第4期
42.Association of improved overall survival with decreased distant metastasis following asparaginase-based chemotherapy and radiotherapy for intermediate- and high-risk early-stage extranodal nasal-type NK/T-cell lymphoma: a CLCG study

机译：基于烷淀戳酶的化疗和放射治疗的中间和高风险早期外鼻鼻型NK / T细胞淋巴瘤的远处转移随着远程转移而改善的整体生存结合随着远程转移而降低
- 作者：X. Zheng;X. He;Y. Yang;X. Liu;L.L. Zhang;B.L. Qu;Q.Z. Zhong;L.T. Qian;X.R. Hou;X.Y. Qiao;H. Wang;Y. Zhu;J.Z. Cao;J.X. Wu;T. Wu;S.Y. Zhu;M. Shi;L.M. Xu;H.L. Zhang;H. Su;Y.Q. Song;J. Zhu;Y.J. Zhang;H.Q. Huang;Y. Wang;F. Chen;L. Yin;S.N. Qi;Y.X. Li
- 期刊名称：《ESMO Open》 | 2021年第4期
43.Assessment of potential process quality indicators for systemic treatment of breast cancer in Belgium: a population-based study

机译：比利时乳腺癌全身治疗潜在流程质量指标评估：基于人群的研究
- 作者：L. van Walle;K. Punie;E. Van Eycken;E. de Azambuja;H. Wildiers;F.P. Duhoux;P. Vuylsteke;A. Barbeaux;N. Van Damme;D. Verhoeven
- 期刊名称：《ESMO Open》 | 2021年第4期
44.Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI diffusion-weighted imaging and 1H-MR spectroscopy compared with histology (subgroup in the RAXO trial)

机译：结直肠癌肝转移到Neoadjuvant或转化疗法的治疗响应：使用MRI扩散加权成像和1H-MR光谱与组织学（raxo试验中的亚组）进行前瞻性多期后续研究
- 作者：A. Uutela;A. Ovissi;A. Hakkarainen;A. Ristimäki;N. Lundbom;R. Kallio;L.M. Soveri;T. Salminen;A. Ålgars;P. Halonen;R. Ristamäki;A. Nordin;R. Blanco Sequeiros;I. Rinta-Kiikka;E. Lantto;J. Virtanen;E. Pääkkö;E. Liukkonen;J. Saunavaara;P. Ryymin;E. Lammentausta;P. Osterlund;H. Isoniemi
- 期刊名称：《ESMO Open》 | 2021年第4期
45.Prognostic impact of six versus eight cycles of standard regimen in patients with diffuse large B-cell lymphoma: propensity score-matching analysis

机译：六种与八个标准方案的预后影响在弥漫性大B细胞淋巴瘤患者中的八个循环：倾向分数匹配分析
- 作者：K. Oiwa;K. Fujita;S. Lee;T. Morishita;H. Tsukasaki;E. Negoro;T. Hara;H. Tsurumi;T. Ueda;T. Yamauchi
- 期刊名称：《ESMO Open》 | 2021年第4期
46.Intratumor morphologic and transcriptomic heterogeneity in V600EBRAF-mutated metastatic colorectal adenocarcinomas

机译：V600Braf-突变转移性结直肠癌腺癌中的细胞内的形态和转录组异质性
- 作者：V. Angerilli;E. Fontana;S. Lonardi;M. Sbaraglia;B. Borelli;G. Munari;R. Salmaso;V. Guzzardo;G. Spolverato;S. Pucciarelli;P. Pilati;J.C. Hahne;F. Bergamo;V. Zagonel;A.P. Dei Tos;A. Sadanandam;F. Loupakis;N. Valeri;M. Fassan
- 期刊名称：《ESMO Open》 | 2021年第4期
47.Identifying and preventing burnout in young oncologists an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Oncology (SEOM)

机译：在年轻肿瘤学家中识别和预防倦怠在Covid-19时代的一个压倒性挑战：对西班牙医学肿瘤学会（SEM）的研究
- 作者：P. Jiménez-Labaig;V. Pacheco-Barcia;A. Cebrià;F. Gálvez;B. Obispo;D. Páez;A. Quílez;T. Quintanar;A. Ramchandani;J. Remon;J. Rogado;D.A. Sánchez;M. Sánchez-Cánovas;E. Sanz-García;A. Sesma;N. Tarazona;A. Cotés;E. González;J. Bosch-Barrera;A. Fernández;E. Felip;R. Vera;Á. Rodríguez-Lescure;E. Élez
- 期刊名称：《ESMO Open》 | 2021年第4期
48.Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI PAGIST)

机译：Pazopanib在晚期胃肠道基质肿瘤中的益处：II期试验结果（SSG XXIPAGIST）
- 作者：M. Eriksson;P. Reichardt;H. Joensuu;A. Krarup-Hansen;O. Hagberg;P. Hohenberger;H. Hagberg;L. Hansson;T. Foukakis;K. Pulkkanen;S. Bauer;D. Goplen;P. Blach Rossen;K. Sundby Hall
- 期刊名称：《ESMO Open》 | 2021年第4期
49.Increased risk of diabetes in cancer survivors: a pooled analysis of 13 population-based cohort studies

机译：癌症幸存者患糖尿病的风险增加：13个基于人群的队列研究的汇总分析
- 作者：Y. Xiao;H. Wang;Y. Tang;J. Yan;L. Cao;Z. Chen;Z. Shao;Z. Mei;Z. Jiang
- 期刊名称：《ESMO Open》 | 2021年第4期
50.Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national multicentric and real-life French cohort (ESME)

机译：转移性炎症乳腺癌：国家多中心和现实法国队列（ESME）的生存结果和预后因素
- 作者：D. Dano;A. Lardy-Cleaud;A. Monneur;N. Quenel-Tueux;C. Levy;M.-A. Mouret-Reynier;B. Coudert;A. Mailliez;J.-M. Ferrero;S. Guiu;M. Campone;T. de La Motte Rouge;T. Petit;B. Pistilli;F. Dalenc;G. Simon;F. Lerebours;S. Chabaud;F. Bertucci;A. Gonçalves
- 期刊名称：《ESMO Open》 | 2021年第4期
51.Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective multicenter real-world study

机译：标准与转移性胃肠内置肿瘤中的regorafenib的个性化时间表：回顾性多中心现实世界研究
- 作者：M. Nannini;A. Rizzo;M.C. Nigro;B. Vincenzi;A. Mazzocca;G. Grignani;A. Merlini;L. D’Ambrosio;F. Tolomeo;G. Badalamenti;L. Incorvaia;A. Bonasera;E. Fumagalli;D. Miliziano;F. Ligorio;A. Brunello;B. Chiusole;S. Gasperoni;M. Novelli;M.A. Pantaleo
- 期刊名称：《ESMO Open》 | 2021年第4期
52.Real-world clinical profile treatment patterns and patient-reported outcomes in a subset of HR+/HER2- advanced breast cancer patients with poor prognostic factors: data from an international study

机译：具有较差预后因素的HR + / HER2晚期乳腺癌患者的患者的现实世界临床型材治疗模式和患者报告的结果：来自国际研究的数据
- 作者：A. Davie;G. Cuyun Carter;A. Rider;A. Bailey;K. Lewis;G. Price;H. Ostojic;F. Ringeisen;X. Pivot
- 期刊名称：《ESMO Open》 | 2021年第4期
53.Skip pattern approach toward the early access of innovative anticancer drugs

机译：跳过创新抗癌药物早期进入的模式方法
- 作者：G. Apolone;A. Ardizzoni;A. Biondi;A. Bortolami;C. Cardone;C.M. Ciniselli;P. Conte;C. Crippa;F. de Braud;M. Duca;S. Gori;G. Gritti;A. Inno;R. Luksch;F. Lussana;M. Maio;G. Pasello;F. Perrone;A. Rambaldi;G. Rossi;D. Signorelli;G. Soverini;M. Valente;P. Verderio;G. Buzzetti
- 期刊名称：《ESMO Open》 | 2021年第4期
54.ESR1 PGR ERBB2 and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6

机译：ESR1PGRERBB2和MKI67患有激素受体阳性早期乳腺癌的绝经后妇女的mRNA表达：ABCSG试验的结果6
- 作者：M. Filipits;M. Rudas;C.F. Singer;F. Fitzal;Z. Bago-Horvath;R. Greil;M. Balic;S.F. Lax;S. Halper;W. Hulla;N.C. Wu;X. Liu;J. Weidler;M. Bates;D. Hlauschek;M. Gnant;P. Dubsky
- 期刊名称：《ESMO Open》 | 2021年第4期
55.Clinical benefit of systemic therapies for recurrent ovarian cancer—ESMO-MCBS scores

机译：经常性卵巢癌癌症 - ESMO-MCBS分数的系统性疗法的临床益处
- 作者：K.E. Broekman;M. van Kruchten;H. van Tinteren;C. Sessa;M. Jalving;A.K.L. Reyners
- 期刊名称：《ESMO Open》 | 2021年第4期
56.Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival

机译：HER2阳性乳腺癌患者的临床特征及探测器预测生存
- 作者：Y. Fan;Y. Wang;L. He;S. Imani;Q. Wen
- 期刊名称：《ESMO Open》 | 2021年第4期
57.Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge

机译：通过基于NGS的多基因面板测试在乳腺/卵巢和胰腺癌患者中检测到BRCA1 / 2之外的其他基因中有害变种对其他基因的影响：看着树篱
- 作者：M. Bono;D. Fanale;L. Incorvaia;D. Cancelliere;A. Fiorino;V. Calò;A. Dimino;C. Filorizzo;L.R. Corsini;C. Brando;G. Madonia;A. Cucinella;R. Scalia;N. Barraco;F. Guadagni;E. Pedone;G. Badalamenti;A. Russo;V. Bazan
- 期刊名称：《ESMO Open》 | 2021年第4期
58.Management of lung cancer patients quality of life in clinical practice: a Delphi study

机译：临床实践中肺癌患者生活质量的管理：DELPHI研究
- 作者：V. Westeel;M. Bourdon;A.B. Cortot;D. Debieuvre;A.-C. Toffart;M. Acquadro;B. Arnould;J. Lambert;F.-E. Cotte;A.-F. Gaudin;H. Lemasson
- 期刊名称：《ESMO Open》 | 2021年第4期
59.How we treat medulloblastoma in adults

机译：我们如何在成人身上治疗medulloblastoma
- 作者：E. Franceschi;C. Seidel;F. Sahm;K.W. Pajtler;P. Hau
- 期刊名称：《ESMO Open》 | 2021年第4期
60.SUNRISE-DI study. The daily sunrise is easier to predict than the benefit of adjuvant treatment in colon cancer

机译：日出 - 迪研究。每日日出更容易预测而不是结肠癌辅助治疗的益处
- 作者：A. Carmona-Bayonas;V. Valentí;P. Jiménez-Fonseca;R. Salazar
- 期刊名称：《ESMO Open》 | 2021年第4期
61.How we treat primary central nervous system lymphoma

机译：我们如何治疗原发性中枢神经系统淋巴瘤
- 作者：T. Calimeri;S. Steffanoni;F. Gagliardi;A. Chiara;A.J.M. Ferreri
- 期刊名称：《ESMO Open》 | 2021年第4期
62.European Reference Network for rare adult solid cancers statement and integration to health care systems of member states: a position paper of the ERN EURACAN

机译：欧洲参考网络用于罕见的成人实体癌症会员国卫生保健系统的陈述和融合：欧元欧元的立场文件
- 作者：J.-Y. Blay;P. Casali;C. Bouvier;C. Dehais;I. Galloway;J. Gietema;J. Halámková;N. Hindi;A. Idbaih;E. Kinloch;H.-J. Klümpen;T. Kolarova;K. Kopeckova;J. Lovey;M. Magalhaes;K. Oselin;S. Piperno-Neumann;A. Ravnsbaek;M. Rogasik;A. Safwat;S. Scheipl;M. Seckl;J. Taylor;M. Temnyk;A. Trama;M. Urbonas;M. Wartenberg;A. Weinman
- 期刊名称：《ESMO Open》 | 2021年第4期
63.Squamous rectal carcinoma: a rare malignancy literature review and management recommendations

机译：鳞状癌：罕见的恶性肿瘤文献综述和管理建议
- 作者：C. Astaras;A. Bornand;T. Koessler
- 期刊名称：《ESMO Open》 | 2021年第4期
64.Cancer and hepatic steatosis

机译：癌症和肝脏脂肪变性
- 作者：R. Paternostro;W. Sieghart;M. Trauner;M. Pinter
- 期刊名称：《ESMO Open》 | 2021年第4期
65.Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)

机译：胸腺上皮肿瘤患者的临床管理：意大利医学肿瘤学协会认可的建议（AIOM）
- 作者：F. Conforti;M. Marino;V. Vitolo;L. Spaggiari;R. Mantegazza;P. Zucali;E. Ruffini;L. di Tommaso;G. Pelosi;M. Barberis;I. Petrini;G. Palmieri;G. Pasello;G. Galli;R. Berardi;M. Garassino;P. Filosso;M. Alloisio;M. Scorsetti;R. Orecchia;L. Pala;L. Abatedaga;S. Cinieri;T. De Pas
- 期刊名称：《ESMO Open》 | 2021年第4期
66.Sacituzumab govitecan and trastuzumab deruxtecan: two new antibody–drug conjugates in the breast cancer treatment landscape

机译：Sacituzumab Govitecan和Trastuzumab Deruxtecan：乳腺癌治疗景观中的两种新抗体 - 药物缀合物
- 作者：E. Adams;H. Wildiers;P. Neven;K. Punie
- 期刊名称：《ESMO Open》 | 2021年第4期
67.Emerging targets for anticancer vaccination: IDH

机译：抗癌疫苗的新兴目标：IDH
- 作者：M. Platten;L. Bunse;W. Wick
- 期刊名称：《ESMO Open》 | 2021年第4期
68.Clinical implications of isolated troponinemia following immune checkpoint inhibitor therapy

机译：免疫检查点抑制作用术后分离肌钙蛋白血症的临床意义
- 作者：D. Delombaerde;D. Vervloet;C. Franssen;L. Croes;F. Gremonprez;H. Prenen;M. Peeters;C. Vulsteke
- 期刊名称：《ESMO Open》 | 2021年第4期
69.Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review

机译：患有神经纤维瘤病患者的新型分子靶向疗法具有无法操作的葡萄球菌神经纤维瘤瘤：全面审查
- 作者：I. Solares;D. Viñal;M. Morales-Conejo;N. Rodriguez-Salas;J. Feliu
- 期刊名称：《ESMO Open》 | 2021年第4期
70.Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature

机译：患有R1192P Anaplastic淋巴瘤激酶突变的难治性转移性嗜肾上腺细胞瘤的患者对Brigatinib的持续反应：奥地利群体医学肿瘤治疗的案例报告下一代测序登记处和文献讨论
- 作者：R. Heregger;F. Huemer;G. Hutarew;S. Hecht;L. Cheveresan;D. Kotzot;E. Schamschula;G. Rinnerthaler;T. Melchardt;L. Weiss;R. Greil
- 期刊名称：《ESMO Open》 | 2021年第4期
71.The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II

机译：肿瘤学专业人员在Covid-19大流行期间的担忧：ESMO恢复力工作队调查II的结果
- 作者：K.H.J. Lim;K. Murali;K. Kamposioras;K. Punie;C. Oing;M. O’Connor;E. Thorne;T. Amaral;P. Garrido;M. Lambertini;B. Devnani;C.B. Westphalen;G. Morgan;J.B.A.G. Haanen;C. Hardy;S. Banerjee
- 期刊名称：《ESMO Open》 | 2021年第4期
72.Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study

机译：Trifluridine / Tipiracil与安慰剂在转移性胃癌中的第三或后期治疗方法：标签研究中的探索性亚组分析
- 作者：J. Tabernero;K. Shitara;A. Zaanan;T. Doi;S. Lorenzen;E. Van Cutsem;L. Fornaro;D.V.T. Catenacci;R. Fougeray;S.R. Moreno;P. Azcue;H.-T. Arkenau;M. Alsina;D.H. Ilson
- 期刊名称：《ESMO Open》 | 2021年第4期
73.Corrigendum to ‘COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)’ ESMO Open Volume 6 Issue 3 June 2021 100165

机译：Covid-19流行病患者意大利癌症研究的勘犯：意大利癌症协会（SIC）的调查ESMO开放第6卷第3款6月2021100165
- 作者：F. Bianchi;E. Dama;F. Di Nicolantonio;G. Baldassarre;I. Guerriero;E. Torchiaro;A. Bruno;G. Blandino;P. Allavena;P. Chiarugi;G. Sozzi;M. D’Incalci;N. Normanno
- 期刊名称：《ESMO Open》 | 2021年第4期
74.Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆

机译：成人患者中的癌症恶病毒：ESMO临床实践指南☆
- 作者：J. Arends;F. Strasser;S. Gonella;T.S. Solheim;C. Madeddu;P. Ravasco;L. Buonaccorso;M.A.E. de van der Schueren;C. Baldwin;M. Chasen;C.I. Ripamonti;gro.omse@senilediuglacinilc
- 期刊名称：《ESMO Open》 | 2021年第3期
75.Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial

机译：Avelumab Plus Axitinib与Sunitinib在Sarcomatoid肾细胞癌中的功效和相关分析：随机临床试验后的HOC分析
- 作者：T.K. Choueiri;J. Larkin;S. Pal;R.J. Motzer;B.I. Rini;B. Venugopal;B. Alekseev;H. Miyake;G. Gravis;M.A. Bilen;S. Hariharan;A. Chudnovsky;K.A. Ching;X.J. Mu;M. Mariani;P.B. Robbins;B. Huang;A. di Pietro;L. Albiges
- 期刊名称：《ESMO Open》 | 2021年第3期
76.Identification of cell surface targets for CAR-T cell therapies and antibody–drug conjugates in breast cancer

机译：鉴别乳腺癌Car-T细胞疗法和抗体 - 药物缀合物的细胞表面靶标
- 作者：F. Schettini;P. Barbao;F. Brasó-Maristany;P. Galván;D. Martínez;L. Paré;S. De Placido;A. Prat;S. Guedan
- 期刊名称：《ESMO Open》 | 2021年第3期
77.Prospective experimental treatment of colorectal cancer patients based on organoid drug responses

机译：基于有机体药物反应的结直肠癌患者的前瞻性实验治疗
- 作者：S.N. Ooft;F. Weeber;L. Schipper;K.K. Dijkstra;C.M. McLean;S. Kaing;J. van de Haar;W. Prevoo;E. van Werkhoven;P. Snaebjornsson;L.R. Hoes;M. Chalabi;D. van der Velden;M. van Leerdam;H. Boot;C. Grootscholten;A.D.R. Huitema;H.J. Bloemendal;E. Cuppen;E.E. Voest
- 期刊名称：《ESMO Open》 | 2021年第3期
78.High body mass index and pre-existing autoimmune disease are associated with an increased risk of immune-related adverse events in cancer patients treated with PD-(L)1 inhibitors across different solid tumors

机译：高体重指数和预先存在的自身免疫疾病与癌症患者的免疫相关不良事件的风险增加有关其在不同实体瘤上用PD-（L）1抑制剂治疗
- 作者：B. Gülave;M.N. Hew;J.S. de Groot;L. Rodwell;S. Teerenstra;B.O. Fabriek
- 期刊名称：《ESMO Open》 | 2021年第3期
79.Increasing the human chorionic gonadotrophin cut-off to ≤1000 IU/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapy

机译：将人绒毛膜促性腺蛋白切断增加至≤1000IU/ L用于在磨牙后妊娠期孕产妇瘤中发育耐甲氨蝶呤的耐药性更多女性多剂蛋白化疗
- 作者：R. Cortés-Charry;L. Hennah;F.E.M. Froeling;D. Short;X. Aguiar;T. Tin;R. Harvey;N. Unsworth;B. Kaur;P. Savage;N. Sarwar;M.J. Seckl
- 期刊名称：《ESMO Open》 | 2021年第3期
80.Organized breast cancer screening not only reduces mortality from breast cancer but also significantly decreases disability-adjusted life years: analysis of the Global Burden of Disease Study and screening programme availability in 130 countries

机译：有组织的乳腺癌筛查不仅降低了乳腺癌的死亡率而且还显着降低了残疾调整后的终身时间：分析了130个国家的全球疾病研究和筛查计划可用性
- 作者：A. Molassiotis;S. Tyrovolas;I. Giné-Vázquez;W. Yeo;M. Aapro;J. Herrstedt
- 期刊名称：《ESMO Open》 | 2021年第3期
81.Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours

机译：患者报告的STARTRK-2：ROS1融合阳性非小细胞肺癌和NTRK融合阳性实体肿瘤的全球II篮研究
- 作者：L. Paz-Ares;F. Barlesi;S. Siena;M.-J. Ahn;A. Drilon;A. Conley;C. Rolfo;J. Wolf;T. Seto;R. Doebele;A. Kapre;D. Chen;S. McCallum;S. Osborne;G. Demetri
- 期刊名称：《ESMO Open》 | 2021年第3期
82.Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort

机译：2008 - 2017年ESME队列2046型转移性乳腺癌患者中亚型整体存活和新疗法的进化
- 作者：T. Grinda;A. Antoine;W. Jacot;C. Blaye;P.-H. Cottu;V. Diéras;F. Dalenc;A. Gonçalves;M. Debled;A. Patsouris;M.-A. Mouret-Reynier;A. Mailliez;F. Clatot;C. Levy;J.-M. Ferrero;I. Desmoulins;L. Uwer;T. Petit;C. Jouannaud;M. Lacroix-Triki;E. Deluche;M. Robain;C. Courtinard;T. Bachelot;E. Brain;D. Pérol;S. Delaloge
- 期刊名称：《ESMO Open》 | 2021年第3期
83.A multicenter cohort study of osimertinib compared with afatinib as first-line treatment for EGFR-mutated non-small-cell lung cancer from practical dataset: CJLSG1903

机译：与AFATINIB为来自实际数据集的EGFR-突变的非小细胞肺癌的一线治疗多中心队列研究与AFATINIB为初级治疗.CJLSG1903
- 作者：K. Ito;M. Morise;K. Wakuda;O. Hataji;T. Shimokawaji;K. Takahashi;N. Furuya;Y. Takeyama;Y. Goto;T. Abe;T. Kato;S. Ozone;S. Ikeda;Y. Kogure;T. Yokoyama;M. Kimura;H. Yoshioka;K. Murotani;M. Kondo;H. Saka
- 期刊名称：《ESMO Open》 | 2021年第3期
84.Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort

机译：免疫炎症生物标志物作为预处理晚期泌尿道癌症患者免疫疗法的预后因素：意大利扫管队的分析
- 作者：G. Fornarini;S.E. Rebuzzi;G.L. Banna;F. Calabrò;G. Scandurra;U. De Giorgi;C. Masini;C. Baldessari;E. Naglieri;C. Caserta;S. Manacorda;M. Maruzzo;M. Milella;C. Buttigliero;R. Tambaro;P. Ermacora;F. Morelli;F. Nolè;C. Astolfi;C.N. Sternberg
- 期刊名称：《ESMO Open》 | 2021年第3期
85.Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer

机译：不匹配修复蛋白质免疫化学和结直肠癌微卫星不稳定性的分子测试之间的不间断
- 作者：A. Guyot DAsnières De Salins;G. Tachon;R. Cohen;L. Karayan-Tapon;A. Junca;E. Frouin;J. Godet;C. Evrard;V. Randrian;A. Duval;M. Svrcek;O. Lascols;S. Vignot;F. Coulet;T. André;J.-F. Fléjou;P. Cervera;D. Tougeron
- 期刊名称：《ESMO Open》 | 2021年第3期
86.Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey

机译：Covid-19对女性的影响比男性肿瘤学家更大吗？肿瘤学妇女的结果（W4O）调查
- 作者：P. Garrido;A.A. Adjei;J. Bajpai;S. Banerjee;A.S. Berghoff;S.P. Choo;E. Felip;A.J.S. Furness;E. Garralda;J. Haanen;A. Letsch;H. Linardou;S. Peters;C. Sessa;J. Tabernero;J. Tsang;J.C-.H. Yang;M.C. Garassino
- 期刊名称：《ESMO Open》 | 2021年第3期
87.Metastatic small bowel adenocarcinoma: role of metastasectomy and systemic chemotherapy

机译：转移性小肠腺癌：雌乳切除术和全身化疗的作用
- 作者：D. Bhamidipati;A. Colina;H. Hwang;H. Wang;M. Katz;K. Fournier;V. Serpas;J. Thomas;R. Sun;R.A. Wolff;K. Raghav;M.J. Overman
- 期刊名称：《ESMO Open》 | 2021年第3期
88.High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients

机译：高BRAF变异等位基因频率与黑色素瘤患者的不同病理特征和对靶治疗的反应性有关
- 作者：E. Berrino;A. Balsamo;A. Pisacane;S. Gallo;P. Becco;U. Miglio;D. Caravelli;S. Poletto;L. Paruzzo;C. Debernardi;C. Piccinelli;A. Zaccagna;P. Rescigno;M. Aglietta;A. Sapino;F. Carnevale-Schianca;T. Venesio
- 期刊名称：《ESMO Open》 | 2021年第3期
89.Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France

机译：由于Covid-19由于Covid-19而延迟了新诊断癌症患者的护理并对法国的癌症死亡率产生估计影响
- 作者：J.Y. Blay;S. Boucher;B. Le Vu;C. Cropet;S. Chabaud;D. Perol;E. Barranger;M. Campone;T. Conroy;C. Coutant;R. De Crevoisier;A. Debreuve-Theresette;J.P. Delord;P. Fumoleau;J. Gentil;F. Gomez;O. Guerin;A. Jaffré;E. Lartigau;C. Lemoine;M.A. Mahe;F.X. Mahon;H. Mathieu-Daude;Y. Merrouche;F. Penault-Llorca;X. Pivot;J.C. Soria;G. Thomas;P. Vera;T. Vermeulin;P. Viens;M. Ychou;S. Beaupere
- 期刊名称：《ESMO Open》 | 2021年第3期
90.Patterns of integrating palliative care into standard oncology in an early ESMO designated center: a 10-year experience

机译：在早期ESMO指定中心将姑息护理到标准肿瘤学中的模式：10年的经验
- 作者：D. Blum;A. Seiler;E. Schmidt;M. Pavic;F. Strasser
- 期刊名称：《ESMO Open》 | 2021年第3期
91.Ten-year assessment of a cancer fast-track programme to connect primary care with oncology: reducing time from initial symptoms to diagnosis and treatment initiation

机译：对癌症快速轨道计划的10年评估以将初级护理与肿瘤进行连接：从初始症状减少到诊断和治疗开始的时间
- 作者：M.T. Martínez;J. Montón-Bueno;S. Simon;B. Ortega;S. Moragon;S. Roselló;A. Insa;J. Navarro;A. Sanmartín;A. Julve;E. Buch;A. Peña;J. Franco;J. Martínez-Jabaloyas;J. Marco;M.J. Forner;A. Cano;A. Silvestre;A. Teruel;A. Lluch;A. Cervantes;I. Chirivella Gonzalez
- 期刊名称：《ESMO Open》 | 2021年第3期
92.Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database

机译：乳腺癌患者对大型真实数据库中的鞘膜细胞转移治疗治疗
- 作者：M. Carausu;M. Carton;A. Darlix;D. Pasquier;M. Leheurteur;M. Debled;M.A. Mouret-Reynier;A. Goncalves;F. Dalenc;B. Verret;M. Campone;P. Augereau;J.M. Ferrero;C. Levy;J.-D. Fumet;C. Lefeuvre-Plesse;T. Petit;L. Uwer;C. Jouannaud;L. Larrouquere;M. Chevrot;C. Courtinard;L. Cabel
- 期刊名称：《ESMO Open》 | 2021年第3期
93.Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort☆

机译：内分泌受体阳性早期乳腺癌中哨素节点微转移的预后影响缺乏预后影响：大型多中心队列的结果☆
- 作者：G. Houvenaeghel;A. de Nonneville;M. Cohen;N. Chopin;C. Coutant;F. Reyal;C. Mazouni;P. Gimbergues;A.-S. Azuar;M.-P. Chauvet;J.-M. Classe;E. Daraï;A. Martinez;R. Rouzier;C.T. de Lara;E. Lambaudie;J. Barrou;A. Goncalves
- 期刊名称：《ESMO Open》 | 2021年第3期
94.SAUL a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors PD-L1 expression and prior platinum therapy

机译：Saul对尿道的化疗预处理的atezolizumab的单臂研究 - 预处理的泌尿道局部晚期或转移癌：通过关键基线因素PD-L1表达和先前铂治疗的结果
- 作者：A. Bamias;A.S. Merseburger;Y. Loriot;N. James;E. Choy;D. Castellano;F. Lopez-Rios;F. Calabrò;M. Kramer;G. de Velasco;R. Zakopoulou;K. Tzannis;C.N. Sternberg
- 期刊名称：《ESMO Open》 | 2021年第3期
95.HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer

机译：HPV CTDNA检测高危HPV类型的化学疗法治疗局部晚期宫颈癌
- 作者：L. Cabel;C. Bonneau;A. Bernard-Tessier;D. Héquet;C. Tran-Perennou;G. Bataillon;R. Rouzier;J.-G. Féron;V. Fourchotte;J.-F. Le Brun;C. Benoît;M. Rodrigues;N. Scher;M. Minsat;M.-E. Legrier;I. Bièche;C. Proudhon;X. Sastre-Garau;F.-C. Bidard;E. Jeannot
- 期刊名称：《ESMO Open》 | 2021年第3期
96.Impact of the COVID-19 pandemic on the care of cancer patients in Spain

机译：Covid-19大流行对西班牙癌症患者护理的影响
- 作者：M. Amador;X. Matias-Guiu;G. Sancho-Pardo;J. Contreras Martinez;J.C. de la Torre-Montero;A. Peuelas Saiz;P. Garrido;R. García-Sanz;Á. Rodríguez-Lescure;L. Paz-Ares
- 期刊名称：《ESMO Open》 | 2021年第3期
97.Effect of timing technique and molecular features on brain control with local therapies in oncogene-driven lung cancer

机译：癌症驱动肺癌局部疗法脑对照对脑对照的影响
- 作者：R.A. El Shafie;K. Seidensaal;F. Bozorgmehr;D. Kazdal;T. Eichkorn;M. Elshiaty;D. Weber;M. Allgäuer;L. König;K. Lang;T. Forster;N. Arians;S. Rieken;C.-P. Heussel;F.J. Herth;M. Thomas;A. Stenzinger;J. Debus;P. Christopoulos
- 期刊名称：《ESMO Open》 | 2021年第3期
98.COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)

机译：Covid-19流行病在意大利受影响的癌症研究：意大利癌症学会（SIC）调查
- 作者：F. Bianchi;E. Dama;F. Di Nicolantonio;G. Baldassarre;I. Guerriero;E. Torchiaro;A. Bruno;G. Blandino;P. Allavena;P. Chiarugi;G. Sozzi;M. D’Incalci;N. Normanno
- 期刊名称：《ESMO Open》 | 2021年第3期
99.Twelve years of European cancer drug approval—a systematic investigation of the ‘magnitude of clinical benefit’

机译：12年欧洲癌症药物批准 - 系统调查对临床效益的严重
- 作者：N. Grössmann;S. Wolf;E. Rothschedl;C. Wild
- 期刊名称：《ESMO Open》 | 2021年第3期
100.Primary tumor side is associated with prognosis of colorectal cancer patients with brain metastases

机译：原发性肿瘤侧与脑转移患者的结肠直肠癌患者的预后有关
- 作者：E.S. Bergen;P. Scherleitner;P. Ferreira;B. Kiesel;C. Müller;G. Widhalm;K. Dieckmann;G. Prager;M. Preusser;A.S. Berghoff
- 期刊名称：《ESMO Open》 | 2021年第3期